120 related articles for article (PubMed ID: 9031776)
1. Site of mistletoe injection observed on In-111 OncoScint imaging.
Choe W
Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
[No Abstract] [Full Text] [Related]
2. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
3. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
4. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
6. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
7. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
8. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
10. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract][Full Text] [Related]
11. Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR).
Sakow NK; Japanwalla M; Tuckson WB; Shields RE
Clin Nucl Med; 1996 Apr; 21(4):332-3. PubMed ID: 8925626
[No Abstract] [Full Text] [Related]
12. Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer.
Su WT; Brachman M; O'Connell TX
Am Surg; 2001 Dec; 67(12):1200-3. PubMed ID: 11768830
[TBL] [Abstract][Full Text] [Related]
13. Splenic metastasis from colon carcinoma imaged using In-111 OncoScint.
Pieslor PC; White CA; Varney RR
Clin Nucl Med; 1995 Jun; 20(6):553-4. PubMed ID: 7648747
[No Abstract] [Full Text] [Related]
14. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup DG
Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
[No Abstract] [Full Text] [Related]
15. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
Bhatia M; Baron PL; Alderman DF; Gordon L
Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody.
Muxi A; Pons F; Vidal-Sicart S; Setoain FJ; Herranz R; Novell F; Fernandez RM; Trias M; Setoain J
Nucl Med Commun; 1999 Feb; 20(2):123-30. PubMed ID: 10088160
[TBL] [Abstract][Full Text] [Related]
17. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
[TBL] [Abstract][Full Text] [Related]
18. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application.
Kim SL; Goldschmid S
Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody imaging of colorectal and ovarian cancer.
Haseman MK
West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
